Gerry Facenna QC and Eric Metcalfe acting for the Information Commissioner in facial recognition case

24 May 2019 | by Monckton Chambers

Gerry Facenna QC and Eric Metcalfe are acting for the Information Commissioner in the claim brought by Ed Bridges, supported by the campaign group Liberty, challenging the use of automated facial recognition technology by South Wales police, which is the lead UK police force trialling the technology. Three UK forces have used facial recognition in […]

Daniel Beard QC successfully represents the Competition Commission of Hong Kong in first cartel case under new law

17 May 2019 | by Monckton Chambers

Competition Commission v W Hing and others CTEA 2/2017; [2019] HKCT3 The Hong Kong Competition Tribunal ruled today on the first cartel case brought under the new HK competition law. The Competition Commission of Hong Kong brought a prosecution against 10 contractors on a major public housing project. The contractors were found to have engaged […]

Majority of Supreme Court holds that benefit cap does not contravene Article 14 ECHR

16 May 2019 | by Monckton Chambers

The Supreme Court has today handed down its long-awaited decision in the “benefit cap” appeals. In a lengthy judgment, comprising separate judgments from five of the seven members of the panel that heard the appeals, the Court has dismissed the appeals by a majority of 5:2 (Lady Hale PSC and Lord Kerr JSC dissenting). The […]

Heathrow third runway scheme survives competition law challenge

01 May 2019 | by Monckton Chambers

The High Court has today handed down judgment in R (Heathrow Hub Ltd) v Secretary of State for Transport [2019] EWHC 1069 (Admin). Heathrow Hub Ltd had challenged the Government’s decision to adopt a National Policy Statement favouring the expansion of Heathrow by way of a new runway to the north-west of the existing ones, […]

High Court rules on binding findings in Servier

17 Apr 2019 | by Monckton Chambers

The High Court has today handed down judgment in Secretary of State for Health and others v Servier Laboratories Limited [2019] EWHC 1004 (Ch). The High Court rejected Servier’s arguments that findings of fact made by the General Court in its judgment in Servier v Commission Case T-691/14 handed down on 12 December 2018 would […]

Paul Harris QC leads for claimants in Merricks v Mastercard: Collective proceedings in competition law revitalised by Court of Appeal

17 Apr 2019 | by Monckton Chambers

On 16 April 2019, the Court of Appeal allowed Mr Merrick’s appeal from the Competition Appeal Tribunal’s (“CAT”) refusal to grant a collective proceedings order (“CPO”). The CAT’s order is, accordingly, set aside and the application for certification is remitted to the CAT for a re-hearing. Paul Harris QC leads on behalf of the claimants […]

Wiltshire Council withdraws proposals for special school closure

28 Mar 2019 | by Monckton Chambers

Wiltshire Council has withdrawn its proposals which may have led to the closure of two special schools, after permission to apply for judicial review was granted by the High Court in relation to the proposals. The Claimants, being groups supporting the two schools, were represented by Ian Wise QC (at the permission hearing) and Steve […]

High Court Grants Declaratory Relief regarding imports from Morocco relating to Western Sahara

21 Mar 2019 | by Conor McCarthy

The High Court has declared that HMRC acted unlawfully in granting preferential tariff treatment to products from Morocco which originated in Western Sahara. HMRC – acting pursuant to advice given by the European Commission – had treated such products as being entitled to preferential tariff treatment. But, following a preliminary reference to the Court of […]

High Court rejects attempt to refer question on data exclusivity periods under the Medicines Directive to the ECJ

21 Mar 2019 | by Monckton Chambers

In a judgment released today, Lewis J has rejected an application by Orion Corporation, a pharmaceutical company, to refer to the ECJ questions relating to the starting point of its period of data exclusivity under the Medicines Directive. The Directive gives pharma companies that obtain a marketing authorisation a period of data exclusivity, during which […]